2006
DOI: 10.1136/thx.2005.040477
|View full text |Cite
|
Sign up to set email alerts
|

Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
65
4
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(78 citation statements)
references
References 25 publications
8
65
4
1
Order By: Relevance
“…2 Subsequent studies have described differences in management and survival between the UK and other comparable European countries. 3,4 It has always been unclear to what extent such variation could be explained by casemix variables (ie patients diagnosed later with more advanced disease or multiple co-morbidities) and to what extent they are the result of differences in standards of specialist care, highlighting the need to establish a high quality national lung cancer audit (NLCA), with the aim of recording information about activity, process and outcomes in lung cancer and, using casemix adjustment, begin to explain the wide variations in outcome. Although the UK cancer registries have collected data on lung cancer since the 1970s they have limited information on a number of important factors, including treatment and the key casemix variables, particularly stage.…”
Section: Introductionmentioning
confidence: 99%
“…2 Subsequent studies have described differences in management and survival between the UK and other comparable European countries. 3,4 It has always been unclear to what extent such variation could be explained by casemix variables (ie patients diagnosed later with more advanced disease or multiple co-morbidities) and to what extent they are the result of differences in standards of specialist care, highlighting the need to establish a high quality national lung cancer audit (NLCA), with the aim of recording information about activity, process and outcomes in lung cancer and, using casemix adjustment, begin to explain the wide variations in outcome. Although the UK cancer registries have collected data on lung cancer since the 1970s they have limited information on a number of important factors, including treatment and the key casemix variables, particularly stage.…”
Section: Introductionmentioning
confidence: 99%
“…There is a wide variation between the different populations in the proportion of those diagnosed incidentally. Looking at countries like ours, it can vary between the 7% reported in Swedish or Italian studies, 20,22 to up to 21% in an English population. 22 However, the fact that the diagnosis of LC was incidental does not imply that the patient was asymptomatic, as shown in our study.…”
Section: 15mentioning
confidence: 74%
“…Looking at countries like ours, it can vary between the 7% reported in Swedish or Italian studies, 20,22 to up to 21% in an English population. 22 However, the fact that the diagnosis of LC was incidental does not imply that the patient was asymptomatic, as shown in our study. In a Swedish study, that clearly differentiated between the symptoms of the patient and the consulting reason that led to the cancer diagnosis, 7% incidental diagnoses were reported, although almost 97% of the patients had symptoms associated with LC at the time of the diagnosis.…”
Section: 15mentioning
confidence: 74%
“…Data from the UK National Lung Cancer Audit in 2009 found that the overall unadjusted proportion of patients who underwent surgical resection was approximately 11%, with regional variations ranging from less than 5% to greater than 25%. [46] Other countries in Europe had much higher rates of resection, such as Italy (24%), [47] the Netherlands (20%) [48] and Sweden (17.5%). [49] The group in the UK suggested that lower resection rates were due to diminished access to specialist thoracic surgeons.…”
Section: Discussionmentioning
confidence: 99%